Skip to search.
 FTSE 100 Down 1.58%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
4.48 Down 0.04(0.88%) 7 Jul 21:00
|After Hours: : 4.48 0.00 (0.00%) 7 Jul 21:32
Add to Portfolio
Prev Close:4.52
Open:4.51
Bid:4.45 x 1000
Ask:4.58 x 300
1y Target Est:7.70
Beta:0.33
Earnings Date:30 Jul - 3 Aug (Est.)
Day's Range:4.40 - 4.60
52wk Range:3.26 - 6.28
Volume:2,890,756
Avg Vol (3m):2,646,370
Market Cap:1.08b
P/E (ttm):N/A
EPS (ttm):-0.27
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARNADown 0.88%1.08b
GSKDown 0.33%100.97b
OREXDown 1.26%589.79m
RHHBYDown 0.06%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):25.79
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.51
Quarterly EPS Est (Jun-15) :-0.14
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):0.42

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback